CCL5 and lung disorder: This study shows for the first time that treatment with an agent specifically scavenging mitochondrial ROS can limit viremia, significantly reduce levels of RANTES chemokine and ameliorate lung and systemic inflammation (Figure 9), implying that modulation of oxidative stress in the context of RSV infection can help diminish lung disease.